BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:48 PM
 | 
Feb 08, 2010
 |  BC Extra  |  Company News

CTIC down on pixantrone briefing documents

Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) fell $0.42 (40%) to $0.64 on Monday after FDA posted briefing documents indicating the company had not met the statistical hurdle in its trial of Pixuvri pixantrone. The briefing documents were posted ahead of an Oncologic...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >